Surmodics is a medical device maker that makes coatings for medical devices and manufactures chemicals for diagnostic immunoassay tests The company will make a drug-coated balloon that will be sold by ...

EDEN PRAIRIE, Minn.--(BUSINESS WIRE)--Surmodics, Inc. (NASDAQ:SRDX), a leading provider of medical device and in vitro diagnostic technologies to the health care ...

It’s taken two years, but Surmodics has finally secured the long-awaited premarket approval from the FDA for its SurVeil drug-coated balloon. Surmodics announced the good news in a Tuesday press ...

Surmodics, Inc. (Nasdaq: SRDX), a leading provider of medical device and in vitro diagnostic technologies to the health care industry, today announced that second quarter of fiscal year 2025 financial ...

Surmodics, Inc. (NASDAQ:SRDX) shares are trading lower in the premarket session on Friday. The firm’s stock dipped following news that the U.S. Federal Trade Commission will challenge the proposed ...

EDEN PRAIRIE, Minn.--(BUSINESS WIRE)--Surmodics, Inc. (NASDAQ: SRDX), the global leader in medical device coating technologies, announced the commercial launch of its most advanced hydrophilic medical ...

GTCR announced its acquisition of Surmodics for $627 million GTCR invested in Biocoat, a specialty manufacturer of hydrophilic biomaterial coatings, services and dip-coating equipment for medical ...

Promising new clinical results to treat cardiovascular disease by coating implanted devices with drugs helped pump up trading activity for a Twin Cities company on Tuesday. Shares for Surmodics Inc.

Surmodics, Inc. SRDX demonstrated strong performance in the last reported quarter. Its loss per share was 51.9% narrower than the market estimate, and sales beat the same by 8.3%. The strong ...

Surmodics SRDX is gaining traction on prudent acquisitions along with portfolio expansion. Recent regulatory clearances and progress with TRANSCEND enrollment have also been key growth drivers. The ...